3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pain
2
Neoplasms
2
Weight Loss
1
Trigger Finger Disorder
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Patient Satisfaction
1
Nose Neoplasms
1
Mucositis
1
Menorrhagia
1
Median Neuropathy
1
Lymphoma, Follicular
1
Leiomyoma
1
Hemorrhage
1
Head and Neck Neoplasms
1
Ganglion Cysts
1
Esthesioneuroblastoma, Olfactory
1
De Quervain Disease
1
Cognitive Dysfunction
1
Cachexia
1
Adenomyosis
1
Abnormalities, Radiation-Induced
1
Interventions
Ipilimumab
98
pembrolizumab
84
Nivolumab
82
aldesleukin
51
Cyclophosphamide
49
Interleukin-2
38
fludarabine phosphate
31
Vemurafenib
31
Dacarbazine
31
dabrafenib
29
trametinib
28
Temozolomide
26
fludarabine
25
CTLA-4 Antigen
18
Bevacizumab
18
Radiosurgery
15
Paclitaxel
15
Carboplatin
14
encorafenib
13
binimetinib
13
Introns
13
talimogene laherparepvec
12
Radiotherapy
12
Interferon alpha-2
12
spartalizumab
11
cobimetinib
10
atezolizumab
10
sargramostim
9
peginterferon alfa-2b
9
montanide ISA 51
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Melanoma
×
Ibuprofen
×
Clear all
No trials found.